Testing prostate-specific antigen levels in capillary blood
Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap)
Heinrich-Heine University, Duesseldorf · NCT06626386
This study is testing whether blood samples taken from a finger prick can give the same results for prostate-specific antigen levels as traditional blood samples taken from a vein.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 45 Years to 70 Years |
| Sex | Male |
| Sponsor | Heinrich-Heine University, Duesseldorf (other) |
| Locations | 1 site (Düsseldorf, North Rhine-Westphalia) |
| Trial ID | NCT06626386 on ClinicalTrials.gov |
What this trial studies
The PSA-Cap study aims to compare the measurement of total prostate-specific antigen (PSA) in serum obtained from venipuncture with that from capillary blood samples. It involves collecting capillary blood droplets from patients during routine PSA testing and analyzing both sample types under various storage conditions. The study also assesses the stability of the samples over time and the impact of transportation on measurement accuracy. Anonymized patient samples are used to ensure confidentiality while comparing results.
Who should consider this trial
Good fit: Ideal candidates for this study are men aged 45 to 70 who are undergoing PSA testing for prostate cancer screening.
Not a fit: Patients who are unable to give informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a less invasive method for PSA testing, making prostate cancer screening more accessible.
How similar studies have performed: While similar studies have explored PSA testing methods, this specific approach of using capillary blood for PSA measurement is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men aged from 45 to 70 years * Informed consent for PSA measurement for prostate cancer screening Exclusion Criteria: * Patients unable to give consent
Where this trial is running
Düsseldorf, North Rhine-Westphalia
- Klinik für Urologie, Universitätsklinikum Düsseldorf — Düsseldorf, North Rhine-Westphalia, Germany (RECRUITING)
Study contacts
- Study coordinator: Martin Wallisch
- Email: martin.wallisch@med.uni-duesseldorf.de
- Phone: +49 015751187144
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Prostate Cancer, Prostate specific Antigen